$SPCX

SpaceX shares upgraded. Argus says AI investments will pay off, and don't bet against Musk

Argus Research upgraded Space Exploration Technologies (SpaceX) to buy from hold, citing expected payback from higher AI-related capital expenditures. Argus kept a 12-month price target of $160, implying 39% upside. SpaceX reported Q2 results beating expectations, while capex rose six-fold to over $18B. Shares rose ~10% early Friday amid volatility from upcoming lockup expirations.

Original reporting
Published Aug 7, 2026, 3:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 3:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SpaceX shares upgraded. Argus says AI investments will pay off, and don't bet against Musk — source image
Decision brief

The 30-second read

$SPCXBullishMed
01

Why it matters

Argus’s upgrade frames AI-driven capex as rapidly monetizable, while the article simultaneously warns that large insider lockup expirations could drive additional selling and keep volatility elevated.

02

Market read

A same-day analyst upgrade with a reiterated price target supports a bullish trading setup, but traders should weigh near-term supply risk from upcoming lockups.

03

What to watch

The article highlights share unlock supply but does not quantify how much of the capex is contractually committed versus flexible, which could affect downside risk if demand slows.

Relevance 7/10Novelty 5/10Timing: pre-market/early trading Friday after Argus upgrade

Background

SpaceX has been volatile since its June IPO, including a July plunge and a Wednesday drop after its first public-company earnings report.

Company-level read

Ticker impact

$SPCXBullishMedium confidence
Context

Argus upgraded SpaceX to buy from hold and reiterated a $160 12-month target, citing rapid payback on AI capex despite higher spending.

Expected impact

Likely supports upside bias in the near term, with elevated volatility around upcoming lockup expirations.

Evidence & confidence

The article’s actionable catalyst is an analyst rating/target change tied to AI capex payback, while it also flags potential selling pressure from large share unlocks later this month and in subsequent months.

Market effects

Reinforces the market narrative that AI infrastructure spending can be monetized quickly for space/launch-adjacent operators.

No specific regional impact described beyond US-listed trading reaction.

Limited; focuses on SpaceX-specific capex, earnings, and lockup supply.

Counterpoint

Even with faster AI payback, the magnitude of capex and upcoming lockups could overwhelm fundamentals and pressure the stock.

Key entities

  • SpaceX

    Subject of the article, with Argus upgrade, reiterated $160 target, and discussion of AI capex and lockup expirations.

  • Argus Research

    Issued the upgrade to buy from hold and reiterated the 12-month price target.

  • Elon Musk

    Referenced for track record and as CEO driving the AI-focused strategy.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.

$SPCXMed

SpaceX Stock Surges 10.5% as Argus Sees Rapid AI Payback

Space Exploration Technologies (NASDAQ:SPCX) rose over 12% in Friday trading after Argus upgraded the stock to Buy from Hold and set a $160 price target. Argus cited faster-than-expected AI spending payback. The company reported Q revenue up 92% to $7.81B, adjusted EBITDA up to $3.54B, and AI revenue up 247% to $2.56B, with AI segment profit. Net loss was $541M and AI capex was $15.83B.